Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Angiodynamics Inc (NQ: ANGO )

6.955 -0.005 (-0.07%)
Streaming Delayed Price Updated: 10:01 AM EST, Dec 11, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 22,898
Open 6.960
Bid (Size) 6.950 (1)
Ask (Size) 6.960 (1)
Prev. Close 6.960
Today's Range 6.905 - 6.965
52wk Range 6.010 - 15.96
Shares Outstanding 38,444,076
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AngioDynamics to Report Fiscal 2024 Second Quarter Financial Results on January 5, 2024
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism
From AngioDynamics, Inc.
Via Business Wire

Performance

YTD
-47.98%
-47.98%
1 Month
+12.00%
+12.00%
3 Month
-3.67%
-3.67%
6 Month
-35.90%
-35.90%
1 Year
-44.49%
-44.49%

More News

Read More
Constellation Brands To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Friday
Via Benzinga
What 4 Analyst Ratings Have To Say About AngioDynamics
Via Benzinga
Why Angiodynamics Stock Sank Today
Via The Motley Fool
Preview: AngioDynamics's Earnings
Via Benzinga
Why AngioDynamics Stock Popped on Monday
Via The Motley Fool
Medical Devices Player AngioDynamics Exceeds Q1 Expectations, Sticks To Annual Guidance
Via Benzinga
S&P 500, Nasdaq Face Uphill Battle As Bond Yields Rise; Analyst Pins Hope On Key Jobs Data This Week
Via Benzinga
Topics Stocks
Exposures US Equities
AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics - Undervalued Gem In Med Tech: Analyst Eyes Stellar Growth With A 'Buy' Stance
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
Via Benzinga
AngioDynamics to Report Fiscal 2024 First Quarter Financial Results on October 4, 2023
From AngioDynamics, Inc.
Via Business Wire
Airbnb, Blackstone Rise On News They'll Join S&P 500 Index
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Performance Food Group, Stride, Progressive, H&R Block And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
AngioDynamics Receives FDA Breakthrough Device Designation for the AngioVac System for the Non-Surgical Removal of Right Heart Vegetation
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics Completes Enrollment for PRESERVE Clinical Study
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics to Participate in a Fireside Chat at the Canaccord Genuity Growth Conference
From AngioDynamics, Inc.
Via Business Wire
Should Growth Investors Buy This Revolutionary Small-Cap Stock?
Via The Motley Fool
AngioDynamics Announces Addition of Lorinda Burgess to Board of Directors
From AngioDynamics, Inc.
Via Business Wire
Why Are AngioDynamics Shares Trading Lower Today
Via Benzinga
Small Caps Lift Stock Futures As Traders Await Inflation Data: Analyst Says 'Now Is A Good Time' To Diversify Portfolios
Via Benzinga
AngioDynamics Reports Fiscal Year 2023 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2024 Guidance
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics, Disney And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
Investor Optimism Improves Ahead Of Inflation Data
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.